Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 54% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 24363.65 | 226 / 226 | 97% | 277.80 | 395 / 406 |
| lung | 96% | 136.83 | 552 / 578 | 19% | 1.58 | 224 / 1155 |
| pancreas | 15% | 2.24 | 48 / 328 | 21% | 0.86 | 37 / 178 |
| peripheral blood | 29% | 22.64 | 268 / 929 | 0% | 0 | 0 / 0 |
| stomach | 11% | 2.90 | 40 / 359 | 3% | 0.08 | 9 / 286 |
| spleen | 14% | 35.60 | 34 / 241 | 0% | 0 | 0 / 0 |
| breast | 12% | 3.80 | 53 / 459 | 2% | 0.34 | 27 / 1118 |
| thymus | 4% | 0.69 | 26 / 653 | 5% | 0.10 | 31 / 605 |
| uterus | 7% | 1.21 | 12 / 170 | 1% | 0.02 | 5 / 459 |
| bladder | 5% | 0.38 | 1 / 21 | 3% | 0.14 | 16 / 504 |
| esophagus | 5% | 0.96 | 68 / 1445 | 2% | 0.05 | 4 / 183 |
| intestine | 5% | 1.05 | 49 / 966 | 1% | 0.88 | 7 / 527 |
| adrenal gland | 6% | 1.22 | 15 / 258 | 0% | 0 | 0 / 230 |
| kidney | 4% | 0.53 | 4 / 89 | 1% | 0.36 | 9 / 901 |
| skin | 4% | 1.28 | 79 / 1809 | 1% | 0.04 | 4 / 472 |
| prostate | 4% | 0.48 | 10 / 245 | 0% | 0.00 | 1 / 502 |
| adipose | 4% | 3.92 | 44 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 3% | 0.36 | 5 / 180 | 0% | 0 | 0 / 430 |
| blood vessel | 3% | 0.67 | 34 / 1335 | 0% | 0 | 0 / 0 |
| brain | 2% | 0.34 | 66 / 2642 | 0% | 0 | 0 / 705 |
| heart | 2% | 0.90 | 20 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| muscle | 2% | 0.28 | 14 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006955 | Biological process | immune response |
| GO_0031640 | Biological process | killing of cells of another organism |
| GO_0050778 | Biological process | positive regulation of immune response |
| GO_0006957 | Biological process | complement activation, alternative pathway |
| GO_0006958 | Biological process | complement activation, classical pathway |
| GO_0006956 | Biological process | complement activation |
| GO_0005615 | Cellular component | extracellular space |
| GO_1903561 | Cellular component | extracellular vesicle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005579 | Cellular component | membrane attack complex |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0044877 | Molecular function | protein-containing complex binding |
| Gene name | C8B |
| Protein name | Complement C8 beta chain Complement component C8 beta chain (Complement component 8 subunit beta) |
| Synonyms | hCG_23458 |
| Description | FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. . FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. . FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. . FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. . FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. . |
| Accessions | A0A8Q3SIA7 A0A8Q3WL56 ENST00000468990.2 ENST00000696144.1 B7Z550 ENST00000696165.1 ENST00000696164.1 Q05CV3 A0A8Q3WM97 ENST00000371237.9 ENST00000695843.1 A0A8Q3SJ17 ENST00000494324.2 ENST00000696166.1 A0A8Q3SI88 P07358 ENST00000695842.1 |